Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 28, 1997
April 20, 2020
a46ecfe6-3346-4604-96dc-b32e5e663fff
Related Documents
Expiration Dating and Stability Testing of Solid Oral Dosage Form Drugs Containing Iron: Guidance for Industry
Guidance DocumentJuly 9, 1997Center for Drug Evaluation and Research
NDAs: Impurities in Drug Substances
Guidance DocumentFebruary 1, 2000Center for Drug Evaluation and Research
National Uniformity for Nonpresciption Drugs - Ingredient Listing for OTC Drugs
Guidance DocumentApril 9, 1998Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox